Trial | NCT02628990  Report issue

Title

Lipid-lowering Effect of Plant Stanol Ester Yoghurt Drinks
The Effect of Plant Stanol Ester Yoghurt Drinks With or Without Added Camelina Oil on Serum Lipids in Comparison to Placebo in Subjects With Mildly to Moderately Elevated Serum Cholesterol Concentrations

  • Phase

    N/A

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Study Participants

    155
The aim is to investigate the effects of yoghurt drinks containing two doses of plant stanol ester either with or without added camelina oil on the serum cholesterol levels in moderately hypercholesterolemic subjects
Study Started
Jun 30
2005
Primary Completion
Aug 31
2005
Study Completion
Nov 30
2005
Last Update
Dec 11
2015
Estimate

Other 1.6 g plant stanols

Lipid-lowering effect of Yoghurt Drink with 1.6 g plant stanols

Other 2 g plant stanols

Lipid-lowering effect of Yoghurt Drink with 2 g plant stanols

Other 1.6 g plant stanols and camelina oil [plant stanol, camelina seed oil]

Lipid-lowering effect of Yoghurt Drink with 1.6 g plant stanols and camelina oil

Other 2 g plant stanols and camelina oil

Lipid-lowering effect of Yoghurt Drink with 2 g plant stanols and camelina oil

Other Placebo

Lipid-lowering effect of Placebo Yoghurt Drink

1.6 g plant stanols Experimental

A yoghurt drink containing plant stanol ester (1.6 grams plant stanols), consumed with a meal daily for 4 weeks

2 g plant stanols Experimental

A yoghurt drink containing plant stanol ester (2 grams plant stanols), consumed with a meal daily for 4 weeks

1.6 g plant stanols and camelina oil Experimental

A yoghurt drink containing plant stanol ester (1.6 grams plant stanols) and camelina oil (2 g), consumed with a meal daily for 4 weeks

2 g plant stanols and camelina oil Experimental

A yoghurt drink containing plant stanol ester (2 grams plant stanols) and camelina oil (2 g), consumed with a meal daily for 4 weeks

Placebo Placebo Comparator

A placebo yoghurt drink, consumed with a meal daily for 4 weeks

Criteria 

Inclusion Criteria:

BMI < 30 kg/m2
moderate hypercholesterolemia (fasting total cholesterol between 5-8 mmol/l)
serum triglycerides < 3 mmol/l.
normal liver, kidney and thyroid function
subjects must voluntarily sign the informed consent

Exclusion Criteria:

use of cholesterol lowering foods or dietary supplements within 21 days before the start of the intervention
lipid lowering medication
history of unstable coronary artery disease (myocardial infarction, coronary artery bypass craft (CABG), percutaneous transluminal coronary angioplasty (PTCA) within the previous 6 months, diabetes, hyperglycemia, temporal ischemic attack and malignant diseases
pregnancy or lactation
alcohol abuse
subjects with intolerance to any ingredient of the test products
No Results Posted